SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-13-003689
Filing Date
2013-03-29
Accepted
2013-03-29 14:52:17
Documents
11
Period of Report
2013-05-21

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14A pdli_pre14a-052113.htm PRE 14A 1082168
2 logo.jpg GRAPHIC 17122
3 mclaughlin.jpg GRAPHIC 6372
4 stone.jpg GRAPHIC 6093
5 pic.jpg GRAPHIC 45504
6 proxycard1.jpg GRAPHIC 92619
7 proxycard2.jpg GRAPHIC 136861
8 proxycard3.jpg GRAPHIC 253329
9 notice1.jpg GRAPHIC 124418
10 notice2.jpg GRAPHIC 218490
11 notice3.jpg GRAPHIC 63680
  Complete submission text file 0001437749-13-003689.txt   2413295
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-19756 | Film No.: 13727507
SIC: 2836 Biological Products, (No Diagnostic Substances)